e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictors of mortality in chronic pulmonary aspergillosis
David Lowes, Khaled Al-Shair, Pippa J. Newton, Julie Morris, Chris Harris, Riina Rautemaa-Richardson, David W. Denning
Source:
Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016
Journal Issue:
February
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Lowes, Khaled Al-Shair, Pippa J. Newton, Julie Morris, Chris Harris, Riina Rautemaa-Richardson, David W. Denning. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF)
Assessment of practice surrounding ABPA diagnosis and screening
Related content which might interest you:
Predicting risk of mortality of chronic pulmonary aspergillosis
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Predictors of non-invasive ventilation outcome in chronic obstructive pulmonary disease and pneumonia
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis
Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016
Year: 2017
PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Short-term mortality in patients with acute symptomatic pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Pulmonary and extrapulmonary morbidity and mortality in COPD
Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course
Year: 2012
Pulmonary hemodynamics and mortality in chronic hypersensitivity pneumonitis
Source: International Congress 2017 – Rare diseases
Year: 2017
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 782-800
Year: 2007
Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017
Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012
Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003
Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis
Source: Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018
Year: 2018
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept